Paper429321
Inactivation of rat renal phosphate-dependent glutaminase with 6-diazo-5-oxo-L-norleucine. Evidence for interaction at the glutamine binding site.
Shapiro RA and 2 others. J Biol Chem, 1979. Cited by 61 papers, by iCite.
Cite this record
ConductScience Library. Inactivation of rat renal phosphate-dependent glutaminase with 6-diazo-5-oxo-L-norleucine. Evidence for interaction at the glutamine binding site. Papers, record 429321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/429321
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Inactivation of rat renal phosphate-dependent glutaminase with 6-diazo-5-oxo-L-norleucine. Evidence for interaction at the glutamine binding site.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Azo Compounds | Major topic |
| Diazooxonorleucine | Major topic |
| Glutaminase | Major topic |
| Kidney | Major topic |
| Phosphates | Major topic |
| Animals | |
| Binding Sites | |
| Glutamine | |
| Kinetics | |
| Protein Binding | |
| Rats |
Source PubMed
Cited by38
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39339370 | Discovery and Optimization of Ergosterol Peroxide Derivatives as Novel Glutaminase 1 Inhibitors for the Treatment of Triple-Negative Breast Cancer. | Molecules | 2024 | https://conductscience.org/library/papers/39339370 | PubMed |
| 36782138 | Identification of four metabolic subtypes and key prognostic markers in lung adenocarcinoma based on glycolytic and glutaminolytic pathways. | BMC Cancer | 2023 | https://conductscience.org/library/papers/36782138 | PubMed |
| 36655131 | Synthesis of Novel Kidney-Type Glutaminase Allosteric Inhibitors Targeting the Critical Lys-320 Residue. | ACS Med Chem Lett | 2023 | https://conductscience.org/library/papers/36655131 | PubMed |
| 34977582 | Biodegradable self-assembly micelles significantly enhanced the solubility, biological stability and in vivo antitumor efficacy of Hexylselen. | RSC Chem Biol | 2021 | https://conductscience.org/library/papers/34977582 | PubMed |
| 34678554 | Modulating glutamine metabolism to control viral immuno-inflammatory lesions. | Cell Immunol | 2021 | https://conductscience.org/library/papers/34678554 | PubMed |
| 33777357 | An efficient synthetic route to l-γ-methyleneglutamine and its amide derivatives, and their selective anticancer activity. | RSC Adv | 2021 | https://conductscience.org/library/papers/33777357 | PubMed |
| 33335484 | From Glucose to Lactate and Transiting Intermediates Through Mitochondria, Bypassing Pyruvate Kinase: Considerations for Cells Exhibiting Dimeric PKM2 or Otherwise Inhibited Kinase Activity. | Front Physiol | 2020 | https://conductscience.org/library/papers/33335484 | PubMed |
| 33322239 | The Molecular 'Myc-anisms' Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33322239 | PubMed |
| 32219214 | Kidney-Type Glutaminase Inhibitor Hexylselen Selectively Kills Cancer Cells via a Three-Pronged Mechanism. | ACS Pharmacol Transl Sci | 2019 | https://conductscience.org/library/papers/32219214 | PubMed |
| 32211323 | Metabolic Plasticity in Chemotherapy Resistance. | Front Oncol | 2020 | https://conductscience.org/library/papers/32211323 | PubMed |
| 32163417 | Glutamine supports the protection of tissue cells against the damage caused by cholesterol-dependent cytolysins from pathogenic bacteria. | PLoS One | 2020 | https://conductscience.org/library/papers/32163417 | PubMed |
| 31055988 | The molecular rationale for therapeutic targeting of glutamine metabolism in pulmonary hypertension. | Expert Opin Ther Targets | 2019 | https://conductscience.org/library/papers/31055988 | PubMed |
| 30198844 | Glutathione de novo synthesis but not recycling process coordinates with glutamine catabolism to control redox homeostasis and directs murine T cell differentiation. | Elife | 2018 | https://conductscience.org/library/papers/30198844 | PubMed |
| 29969024 | Recent Progress in the Discovery of Allosteric Inhibitors of Kidney-Type Glutaminase. | J Med Chem | 2019 | https://conductscience.org/library/papers/29969024 | PubMed |
| 29888760 | Evaluating the Analgesic Effect of the GLS Inhibitor 6-Diazo-5-Oxo-L-Norleucine in Vivo. | Pharm Pharmacol Int J | 2016 | https://conductscience.org/library/papers/29888760 | PubMed |
| 29788892 | Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer. | Curr Top Med Chem | 2018 | https://conductscience.org/library/papers/29788892 | PubMed |
| 29750203 | Evaluating the Toxicity of the Analgesic Glutaminase Inhibitor 6-Diazo-5-Oxo-L-Norleucine in vitro and on Rat Dermal Skin Fibroblasts. | MOJ Toxicol | 2015 | https://conductscience.org/library/papers/29750203 | PubMed |
| 28950000 | Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition. | PLoS One | 2017 | https://conductscience.org/library/papers/28950000 | PubMed |
| 28115589 | Targeting Metabolism as a Novel Therapeutic Approach to Autoimmunity, Inflammation, and Transplantation. | J Immunol | 2017 | https://conductscience.org/library/papers/28115589 | PubMed |
| 26640142 | Targeting glutamine metabolism in multiple myeloma enhances BIM binding to BCL-2 eliciting synthetic lethality to venetoclax. | Oncogene | 2016 | https://conductscience.org/library/papers/26640142 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/429321
GET https://conductscience.org/api/papers/v1/429321/cited_by?page=2